Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02151513 · ClinicalTrials.gov registry record
Pilot Study on the Effect of Intrathecal Opioids on Immune Function in Humans With Cancer Pain
A clinical trial of Cancer Associated Pain, sponsored by University of Utah.
- Completed
- Registry status
- 51
- Enrollment target
- 1
- Study location
NCT02151513: Completed study of Cancer Associated Pain, sponsored by University of Utah.
NCT02151513 is a study of Cancer Associated Pain that has completed, run by University of Utah. The registered enrollment target is 51 participants. The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02151513, a study of Cancer Associated Pain, has completed, sponsored by University of Utah.
- COMPLETED
- Registry status
- 51 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to examine the changes in immune function, as measured by biomarkers in the blood, that happen with intrathecal (spinal) delivery of opioid medications for the treatment of moderate to severe cancer pain. Hypothesis: Treatment of pain with intrathecal (spinal) therapy is associated with little alteration of immune function as measured by biomarkers in the blood of cancer patients with moderate to severe pain.
Primary Outcome
Change in biomarker values as measured by blood
Conditions Studied
Interventions
- DEVICE Intrathecal Pump Placement
Study Locations (1)
Utah
- Huntsman Cancer Hosptial - Salt Lake City
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 51 participants |
| Start Date | 2014-04-01 |
| Est. Completion | 2018-06-01 |
What the finished NCT02151513 record still lists
NCT02151513 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 51 participants, a relatively small participant target.
The record links to 1 condition, with Cancer Associated Pain appearing as the primary indexed condition, and to 1 intervention - of which Intrathecal Pump Placement is the first listed.
NCT02151513 reports a single indexed study location in Utah.
Frequently Asked Questions
What is clinical trial NCT02151513 about?
NCT02151513 is a clinical study titled "Pilot Study on the Effect of Intrathecal Opioids on Immune Function in Humans With Cancer Pain". The purpose of this study is to examine the changes in immune function, as measured by biomarkers in the blood, that happen with intrathecal (spinal) delivery of opioid medications for the treatment of moderate to severe cancer pain. Hypothesis: Treatment of pain with intrathecal (spinal) therapy i...
What is the current status of trial NCT02151513?
This trial is currently completed. The enrollment target is 51 participants. The study started on 2014-04-01. Estimated completion is 2018-06-01.
What conditions does trial NCT02151513 study?
This clinical trial studies the following conditions: Cancer Associated Pain.
What interventions are being tested in trial NCT02151513?
The interventions under investigation include: Intrathecal Pump Placement (DEVICE).
Who is sponsoring clinical trial NCT02151513?
This trial is sponsored by University of Utah, which has 818 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02151513 being conducted?
This trial has 1 study location across Utah. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Cancer Associated Pain
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02701153 · 51 participants · NA
Phase II Study of 5-Day Hypofractionated Preoperative Radiation Therapy for Soft Tissue Sarcomas: Expansion Cohort
- NCT03663790 · 51 participants · NA
Effects of Gait Retraining on Lower Extremity Biomechanics
- NCT03874052 · 51 participants · Phase 1
Ruxolitinib in Combination With Venetoclax With and Without Azacitidine in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia
- NCT04704661 · 51 participants · Phase 1
Testing the Combination of Two Anti-cancer Drugs, DS-8201a and AZD6738, for The Treatment of Advanced Solid Tumors Expressing the HER2 Protein or Gene, The DASH Trial
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI